Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Tazorac launched in Canada

Feb. 19, 1998

HGS's KGF-2 enters clinical testing

Feb. 13, 1998

Promising results with AlloDerm reported

Feb. 10, 1998

Celtrix and Genzyme expand collaboration

Feb. 10, 1998

Psovascar enters phase I/II for psoriasis

Feb. 9, 1998

P&U receives three-year marketing exclusivity for Rogaine Extra Strength

Feb. 6, 1998

Avita gel can now be launched in U.S.

Feb. 5, 1998

ProCyte reports results from U.K. leg ulcer study

Feb. 5, 1998

Promising preclinical results reported for Resolve

Feb. 4, 1998

PB-005 studied in postsurgical wound healing

Feb. 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...